News
Venture Leaders Medtech: Meet the 2024 Swiss Team
10 promising startups were selected by Venture Leaders Medtech. 3 of them are from the Swiss Health Valley. They will travel to Boston from 4 to 8 November as part of the Swiss National Startup Team where they will meet investors. Apersys (ZH): Overcomes organ shortage with an advanced perfusion system. Metadvice (VD): …
Read MoreTOP 100 Swiss Startup Award 2024
This year, 15 startups from the Swiss Health Valley we ranked in the prestigious TOP 100 Swiss Startup Award 2024, including HAYA Therapeutics at #5. The 14th ceremony of the TOP 100 Swiss Startup Award took place in Lausanne and was attended by a curated audience comprising startup founders, investors, and key partners…
Read MoreHAYA Therapeutics Announces $1 billion Collaboration with Lilly
The Biopôle-based biotech company and the American pharma giant partner to discover novel regulatory genome targets for obesity and related metabolic conditions using HAYA Therapeutics proprietary RNA platform HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics for chronic diseases, announced a multi-year agreement with Eli Lilly and Company to apply…
Read MoreLife Sciences account for 10% of the canton of Fribourg economy
According to a BAK Economy study, life sciences generated added value of over CHF 1.5 billion in 2023 and employed 3,300 full-time equivalents (FTEs). Through value chains, numerous companies in other economic sectors also benefit from the activities of the life sciences industry. Thus, a total added value of 1.96 billion francs, representing 10% of…
Read MorePlair brings its Rapid-C+ on the market
Rapid-C+, an advanced real-time air microbial detector that sets new standards in environmental monitoring, is now on the market. The device was designed by Plair, a Geneva-based startup. Rapid-C+ uses patented biofluorescent particle counting technology to detect and identify viable contaminants in real time. Its state-of-the-art features include laser-based light scattering and fluorescence…
Read MoreThree life sciences projects win FONGIT Innovation Fund (FIF) financing
Three innovative projects in the life sciences sectors took home funding from the FONGIT Innovation Fund (FIF) in Geneva: two CHF 100k seed loans for Adjust Medical SA, and Clee Medical; and one CHF 50k grant for Neurovia Bioelectronics. Seed Loan of CHF 100,000 awarded to Adjust Medical SA Primary mitral regurgitation (MR)…
Read MoreThe Swiss Institute of Bioinformatics has launches the Centre for Pathogen Bioinformatics
The Centre aims to enhance Switzerland’s role in global pathogen bioinformatics research, providing expertise and services to federal authorities and the international research community. This will support pandemic preparedness and real-time pathogen surveillance. The Centre will contribute to the pathogen response and public health strategies at both national and international scale. It will…
Read MoredEEGtal receives CHF 10’000 from Venture Kick
dEEGtal, who is developing a software for epilepsy diagnosis, has received Venture Kick’s first financial and entrepreneurial support stage with CHF 10’000. The diagnosis of epilepsy is mostly based on visual interpretation of the electroencephalogram (EEG). This method inherently does not provide a diagnosis in 75-80% of the cases, making the diagnosis challenging,…
Read MoreExogems secures CHF 500K in seed-stage financing from business angels
Exogems secures CHF 500’000 in seed-stage financing from business angels to advance therapeutic exosome development. Exogems SA, a pioneering Swiss biotech company developing innovative therapeutic exosomes derived from microfragmented adipose tissue, today announced the successful completion of a CHF 500’000 fundraising round from business angels. This significant investment will fuel the company’s mission…
Read MoreJuliette Lemaignen appointed Director of the Ambulatory Surgery Centre (CCA)
Juliette Lemaignen will take over as director of the Centre for Ambulatory Surgery (CCA) on 1 September 2024. Created jointly by Geneva University Hospitals (HUG) and Hirslanden, it will be operational by the end of 2025. It will be the largest ambulatory surgery centre in Switzerland. Since 2015, Juliette Lemaignen, 45, has been…
Read More